US Stock MarketDetailed Quotes
BNTX BioNTech
- 113.080
- +1.740+1.56%
Close Dec 20 16:00 ET
- 113.080
- 0.0000.00%
Post 20:01 ET
27.11BMarket Cap-56.26P/E (TTM)
115.340High109.800Low924.90KVolume110.760Open111.340Pre Close104.65MTurnover0.99%Turnover Ratio28.49P/E (Static)239.74MShares131.49052wk High1.37P/B10.53BFloat Cap76.53052wk Low--Dividend TTM93.12MShs Float457.931Historical High--Div YieldTTM4.98%Amplitude12.361Historical Low113.151Avg Price1Lot Size
BioNTech Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -178.76%-638.9M | -62.91%1.63B | 53.16%-317.3M | -60.44%5.37B | 2.62%850.9M | -83.03%811.2M | 11.93%4.39B | -116.73%-677.4M | 1,426.06%13.58B | 515.64%829.2M |
| Net income from continuing operations | -30.21%158.7M | -95.49%-805.8M | -146.88%-331.8M | -90.84%1.19B | -79.10%663.2M | -90.70%227.4M | -117.77%-412.2M | -85.90%707.7M | -13.91%12.95B | -32.70%3.17B |
| Operating gains losses | -101.46%-41.5M | 96.92%-8.4M | -120.85%-27M | -130.82%-118.7M | -91.37%45.3M | -118.05%-20.6M | -5.82%-272.9M | 2,983.33%129.5M | 218.27%385.1M | 1,047.11%524.7M |
| Depreciation and amortization | 7.51%44.4M | 56.43%49.9M | 21.97%38.3M | 48.74%183.4M | 171.72%78.8M | 23.28%41.3M | -3.92%31.9M | 13.77%31.4M | 63.96%123.3M | 11.54%29M |
| Other non cash items | -58.73%-239.2M | 10.60%-140M | 78.70%-172.5M | -328.16%-1.28B | -89.70%-158.4M | -2,854.90%-150.7M | -7,557.14%-156.6M | -281.26%-809.8M | -249.62%-297.9M | -1,310.14%-83.5M |
| Change In working capital | -205.61%-675.3M | -49.72%2.37B | 366.46%222.5M | 23.38%5.57B | 112.47%182.8M | -77.83%639.4M | 80.73%4.7B | -90.41%47.7M | 142.11%4.52B | -0.45%-1.47B |
| -Change in receivables | -231.53%-830.2M | -61.33%1.6B | -44.26%498.2M | 22.98%5.37B | 55.47%-288M | -71.89%631.2M | 30.31%4.14B | 321.51%893.8M | 137.01%4.37B | 62.24%-646.8M |
| -Change in inventory | 11.45%37M | 121.37%5.3M | -20.65%12.3M | 30.21%81.9M | 140.06%58M | -54.46%33.2M | -127.07%-24.8M | -64.12%15.5M | 114.35%62.9M | -32.72%-144.8M |
| -Change in payables and accrued expense | 571.60%117.9M | 28.36%760.8M | 66.57%-288M | 38.74%118.9M | 161.19%412.8M | -104.42%-25M | 189.38%592.7M | -200.48%-861.6M | -94.35%85.7M | -286.25%-674.6M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -178.76%-638.9M | -62.91%1.63B | 53.16%-317.3M | -60.44%5.37B | 2.62%850.9M | -83.03%811.2M | 11.93%4.39B | -116.73%-677.4M | 1,426.06%13.58B | 515.64%829.2M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 88.47%-142.1M | 89.47%-241.4M | -213.35%-2.3B | -19,601.13%-6.95B | -1,573.98%-2.7B | -1,379.23%-1.23B | -2,823.21%-2.29B | -355.88%-735.4M | 93.76%-35.3M | -61.16%-161M |
| Net PPE purchase and sale | -34.26%-72.5M | -31.55%-88.4M | -29.42%-58.5M | 23.89%-250.1M | 38.64%-83.7M | 30.32%-54M | 4.82%-67.2M | -2.49%-45.2M | -164.79%-328.6M | -264.71%-136.4M |
| Net intangibles purchase and sale | 89.51%-10.2M | 78.23%-52.7M | -716.67%-78.4M | -1,235.48%-455.4M | -1,248.10%-106.5M | -1,968.09%-97.2M | -4,943.75%-242.1M | 42.51%-9.6M | -28.68%-34.1M | 43.57%-7.9M |
| Net business purchase and sale | --0 | ---- | ---- | ---336.9M | --0 | ---336.9M | ---- | ---- | --0 | --0 |
| Net investment purchase and sale | 92.02%-59.4M | 94.94%-100.3M | -218.47%-2.17B | -1,905.77%-5.91B | -14,899.40%-2.5B | -67,545.45%-744.1M | -65,983.33%-1.98B | -295.46%-680.6M | 182.95%327.4M | 39.71%-16.7M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 88.47%-142.1M | 89.47%-241.4M | -213.35%-2.3B | -19,601.13%-6.95B | -1,573.98%-2.7B | -1,379.23%-1.23B | -2,823.21%-2.29B | -355.88%-735.4M | 93.76%-35.3M | -61.16%-161M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 97.46%-7.9M | 85.99%-22.9M | 97.32%-7.8M | 45.14%-778.6M | 80.06%-12.9M | 52.40%-311M | 79.09%-163.4M | -462.76%-291.3M | -1,606.69%-1.42B | -32.31%-64.7M |
| Net issuance payments of debt | 15.05%-7.9M | -143.62%-22.9M | 16.13%-7.8M | 32.15%-40.1M | -34.44%-12.1M | 3.13%-9.3M | 8.74%-9.4M | 69.21%-9.3M | 11.39%-59.1M | 81.60%-9M |
| Net common stock issuance | --0 | --0 | --0 | 15.69%-738.5M | 98.56%-800K | 53.14%-301.7M | 46.32%-154M | -355.20%-282M | -644.38%-875.9M | ---55.7M |
| Cash dividends paid | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---484.3M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 97.46%-7.9M | 85.99%-22.9M | 97.32%-7.8M | 45.14%-778.6M | 80.06%-12.9M | 52.40%-311M | 79.09%-163.4M | -462.76%-291.3M | -1,606.69%-1.42B | -32.31%-64.7M |
| Net cash flow | ||||||||||
| Beginning cash position | -26.75%10.38B | -26.08%8.98B | -15.94%11.66B | 719.70%13.88B | 0.54%13.5B | 51.76%14.17B | 97.01%12.14B | 719.70%13.88B | 39.87%1.69B | 562.67%13.42B |
| Current changes in cash | -7.77%-788.9M | -29.44%1.36B | -54.30%-2.63B | -119.48%-2.36B | -407.72%-1.86B | -118.11%-732M | -36.86%1.93B | -138.57%-1.7B | 2,801.58%12.12B | 273.27%603.5M |
| Effect of exchange rate changes | -39.87%36.8M | -59.21%37.2M | -112.55%-57.6M | 152.18%150.3M | 116.44%25M | 31.05%61.2M | -18.21%91.2M | -150.65%-27.1M | -7.88%59.6M | -1,094.12%-152.1M |
| End cash Position | -28.68%9.62B | -26.75%10.38B | -26.08%8.98B | -15.94%11.66B | -15.94%11.66B | 0.54%13.5B | 51.76%14.17B | 97.01%12.14B | 719.70%13.88B | 719.70%13.88B |
| Free cash flow | -209.38%-721.9M | -63.56%1.49B | 37.97%-454.2M | -64.69%4.67B | -3.51%660.7M | -85.95%660M | 6.08%4.08B | -118.35%-732.2M | 1,696.13%13.21B | 370.74%684.7M |
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data
